Xiaolun Wang
Mirati Therapeutics (United States) · 44 works · 2,175 citations · h-index 16
Top works
- Identification of MRTX1133, a Noncovalent, Potent, and Selective KRAS G12D Inhibitor
- Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor
- Strained Silacycles in Organic Synthesis: A New Reagent for the Enantioselective Allylation of Aldehydes
- Fragment-Based Discovery of MRTX1719, a Synthetic Lethal Inhibitor of the PRMT5•MTA Complex for the Treatment of MTAP -Deleted Cancers
- Conformation-Specific Effects of Raf Kinase Inhibitors
- Strained silacycle-catalyzed asymmetric Diels–Alder cycloadditions: the first highly enantioselective silicon Lewis acid catalyst
- Strained Silacycles in Organic Synthesis: The Tandem Aldol−Allylation Reaction
- Tandem Aldol−Allylation and Aldol−Aldol Reactions with Ketone-Derived Enolsilanes: Highly Diastereoselective Single-Step Synthesis of Complex Tertiary Carbinols
- Design and Discovery of MRTX0902, a Potent, Selective, Brain-Penetrant, and Orally Bioavailable Inhibitor of the SOS1:KRAS Protein–Protein Interaction
- Structure-Based Design of ASK1 Inhibitors as Potential Agents for Heart Failure
- Reduction of Aromatic azo-, azoxy- and Nitrocompounds by Ultrasonically Activated Nickel
- A new Procedure to Azoarene From Azoxyarene by Ultrasonic Dispersed Potassium
- Dramatic Effect of Solvent Hydrogen Bond Basicity on the Regiochemistry of SNAr Reactions of Electron-Deficient Polyfluoroarenes
- Discovery of highly potent and selective type I B-Raf kinase inhibitors
- Syntheses Of Ketene Dithioacetal Derivatives Of 2,5-Piperazinedione
- N-Alkylation of 2-Methyl-2-Imidazolines by Phase Transfer Catalysis Without Solvent
- A new Procedure to 2-(2-Aryl-2-Aminoethenyl)-4,4-Dimethyl-2-Oxazolines Under Ultrasonically Dispersed Potassium—t-BuCl—i-Pr2NH System
- Discovery of indazoles as inhibitors of Tpl2 kinase
- Acetyl-CoA carboxylase 1 and 2 inhibition ameliorates steatosis and hepatic fibrosis in a MC4R knockout murine model of nonalcoholic steatohepatitis
- Discovery of Pyridopyrimidinones that Selectively Inhibit the H1047R PI3Kα Mutant Protein